Weekly update
Companies
AI-cruiter
Recruiting service
Nkarta Therapeutics
Founded:
2015
Location:
South SF, CA
Employee range:
50 - 200
Clinical stage:
Clin1
Therapy area:
AML , MDS
Drug types:
ONC
Lead product:
NKX101
Product link:
https://www.nkartatx.com/pipeline/
Funding:
$200M stock Apr 2022; $289.8M IPO Jul 2020; $114M B Sep 2019; $11M 2015
Investors:
Samsara, NEA Ventures, SR One, Novo Holdings, Amgen Ventures, Deerfield Management, Life Science Partners, Logos Capital and RA Capital Management
nkartatx.com
linkedin.com
job board
Short description:
Allogeneic cellular immunotherapy platform
Drug notes:
Also Clin0 multiple cancers; NKX019 Clin1 B cell malignancies; undisclosed RD oncology; undisclosed RD undisclosed
Long description:
Contact us to add description.
Jobs:
Main
Home
Weekly update
Companies
AI-cruiter
Recruiting service
© 2023 Work In Biotech LLC
Personal data
Terms of Service
Privacy Policy
Contact: recruit@workinbiotech.com